Outcome of subjects with elevated serum creatinine in a community-based mass screening
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
The outcome and prognosis of screened subjects with elevated levels of serum creatinine (>-176.8 μmol/L [≥2.0 mg/dL]) in a community-based mass health screening were examined in Okinawa, Japan.
From 1983 to 1992, a total of more than 1.24 million people had received at least 1 screening by the Okinawa General Health Maintenance Association. The status of 250,091 individuals for whom data on serum creatine levels was available, as of January 1, 1996, was examined by using information from the Okinawa Dialysis Study registry, which included data on the end-stage renal disease (ESRD) program, and by reviewing the medical charts.
A total of 289 screened subjects (187 men and 102 women) were investigated in this study. The total duration of observation was 1081.8 person-years. Clinical demographics and the incidence of ESRD, and the death of patients with ESRD before starting dialysis therapy (ESRD+death) were compared in 2 consecutive periods: A (1983 to 1987) and B (1988 to 1992). The incidence of ESRD and ESRD+death was 122.4 (161.5) per 1000 person-years in period A, whereas that of period B was 143.8 (170.2) per 1000 person-years. In the period 1988 to 1992, the hazards ratio for ESRD and ESRD+death was 1.50 and 1.38, respectively. The 95% confidence interval was 1.05 to 2.15 and 0.99 to 1.91, respectively, when compared to the period of 1983 to 1987.
This study shows that the risk of ESRD and ESRD+death is not decreasing, therefore the current strategy for the prevention of ESRD is not satistactory. Further study is needed to determine the underlying causes and mechanisms of the progression of renal disease.
- Hull AR, Parker TF III. Proceedings from the morbidity, mortality and prescription of dialysis symposium, Dallas, TX, September 15 to 19, 1989. Am J Kidney Dis 1990;15:375–385.
- Iseki K, Kawazoe N, Osawa A, Fukiyama K. Survival analysis of dialysis patients in Okinawa, Japan (1971–1990). Kidney Int 1993;43:404–409.
- Kinjo K, Kimura Y, Shinzato Y, Tomori M, Komine Y, Kawazoe N, Takishita S, Fukiyama K, and the COSMO Group. An epidemiological analysis of cardiovascular diseases in Okinawa, Japan. Hypertens Res 1992; 15:111–119.
- Iseki K, Iseki C, Ikemiya Y, Fukiyama K. Risk of developing end-stage renal disease in a cohort of mass screening. Kidney Int 1996;49:800–805.
- Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE, Shulman NB, Stamler J. Blood pressure and end-stage renal disease in men. N Engl J Med 1996; 334:13–18. CrossRef
- MacMahon S. Blood pressure and the risks of cardiovascular disease. In: Swales JD (ed) Textbook of hypertension. Cambridge. Blackwell Science, 1994:46–57.
- Mitch WE, Walser M, Buffington GA, Lemann J Jr. A simple method for estimating progression of chronic renal failure. Lancet 1976;ii:1326–1328. CrossRef
- Rutherford WE, Blondin J, Miller JP, Greenwalt AS, Vavra JD. Chronic progressive renal disease: rate of change of serum creatinine concentration. Kidney Int 1977;11:62–70.
- Iseki K, Kawazoe N, Fukiyama K. Serum albumin is a strong predictor of death in chronic dialysis patients. Kidney Int 1993;44:115–119.
- Iseki K, Miyasato F, Oura T, Uehara H, Nishime K, Fukiyama K. An epidemiologic analysis of end-stage lupus nephritis. Am J Kidney Dis 1994;23:547–554.
- Mailloux LU, Bellucci AG, Wilkes BM, Napolitano B, Mossey RT, Lesser M, Bluestone PA. Mortality in dialysis patients: analysis of the causes of death. Am J Kidney Dis 1991;18:326–335.
- Iseki K, Ikemiya Y, Fukiyama K. Risk factors of end-stage renal disease and serum creatinine in a community-based mass screening. Kidney Int 1997;51:850–854.
- Sunagawa H, Iseki K, Nishime K, Uehara H, Toma S, Kinjo K, Fukiyama K. Epidemiologic analysis of diabetic patients on chronic dialysis. Nephron 1996; 74:361–366. CrossRef
- Simon O, Ramee MP, Autuly V, Laurence E, Charasse C, Cam G, Ang KS. Epidemiology of primary glomerular disease in a French region. Variations according to period and age. Kidney Int 1994;46:1192–1198.
- Iseki K, Morita O, Fukiyama K. Seasonal variation in the incidence of end-stage renal disease. Am J Nephrol 1996;16:375–381.
- Bergstrom J, Alverstrand A, Bucht H, Gutierrez A. Progression of chronic renal failure is retarded with more frequent clinical follow-ups and better blood pressure control. Clin Nephrol 1996;25:1–6.
- Donadio JV Jr, Bergstralh EJ, Offord KP, Spencer DC, Holley KE, Mayo Nephrology Collaborative Group. A controlled trial of fish oil in IgA nephropathy. N Engl J Med 1994;331:1194–1199. CrossRef
- Ronco PM, Flahault A. Editorials. Drug-induced end-stage renal disease. N Engl J Med 1994;331:1711–1712.
- Perneger TV, Whelton PK, Klag MJ. Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteriodal antiinflammatory drugs. N Engl J Med 1994;331:1675–1679. CrossRef
- Health and Welfare Statistics Association: Health Services in Japan (Kokumin Eisei No Doko). Indices of Health and Welfare (Kosei No Shihyo) (in Japanese). Tokyo: Ministry of Health and Welfare, 1990;37:S79-S86.
- Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G, for the Modification of Diet in Renal Disease Study Group. The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. N Engl J Med 1994; 330:877–884. CrossRef
- Barmot MG, Smith GD. Why are the Japanese living longer? Br Med J 1989;299:1547–1551. CrossRef
- Iseki K, Nishime K, Uehara H, Osawa A, Fukiyama K. Effect of renal diseases and comorbid conditions on survival in chronic dialysis patients. Nephron 1994; 68:80–86.
- Brazy PC, Fitzwilliam JF. Progressive renal disease: role of race and antihypertensive medications. Kidney Int 1990;37:1113–1119.
- Lewis EJ, Hunsicker LG, Bain RP, Rohde RD, for the Collaborative Study Group. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993;329:1456–1462. CrossRef
- Yoshida H, Mitarai T, Kawamura T, Kitajima T, Miyazaki Y, Nagasawa R, Kawaguchi Y, Kubo H, Ichikawa I, Sakai O. Role of the deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest 1995;96:2162–2169. CrossRef
- Maschio G, Alberti D, Janin G, Locatelli F, Mann, JFE, Motolese M, Ponticelli C, Ritz E, Zucchelli P, and the Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. Effect of the angiotensin-converting enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 1996;334:939–945. CrossRef
- Outcome of subjects with elevated serum creatinine in a community-based mass screening
Clinical and Experimental Nephrology
Volume 2, Issue 1 , pp 31-37
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- serum creatinine
- mass screening
- end-stage renal disease
- Industry Sectors
- Author Affiliations
- 1. Dialysis Unit, University of The Ryukyus, 207 Uehara, 903-0215, Okinawa, Japan
- 2. Okinawa General Health Maintenance Association, Okinawa, Japan
- 3. Third Department of Internal Medicine, University of The Ryukyus, 207 Uehara, 903-0215, Okinawa, Japan